Plain-English translation of NCT05498974 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a large registry study that aims to gather detailed information from 20,000 people living with type 1 diabetes across China. Researchers want to understand how the disease develops, how well people's blood sugar is controlled, what complications people experience, and what factors increase risk. By collecting this information, doctors hope to learn more about type 1 diabetes in Chinese populations and ultimately improve care.
Type 1 diabetes affects people of all ages, but we don't have complete information about how it progresses, which people face the highest risks, or what complications are most common in China. This study exists to fill those gaps so doctors can better predict who might develop problems and how to prevent them.
You likely qualify if…
You likely don't qualify if…
As a participant, you would share your medical information, diabetes history, and health records with the research team. You may complete surveys or questionnaires about your diabetes management and any complications you've experienced. The study involves no new medications or procedures — it simply gathers existing information from your medical care to help researchers better understand type 1 diabetes patterns.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
China